Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages 653-662

  Zhang, Lei ^a   Grennan Jones, Fiona ^a   Lane, Carol ^b   Rees, D Aled ^a   Dayan, Colin M ^a   Ludgate, Marian ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HYALURONIC ACID; HYALURONIC ACID SYNTHASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; SOMATOMEDIN C; THYROTROPIN; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALURONIC ACID SYNTHASE 1 GENE; HYALURONIC ACID SYNTHASE 2 GENE; HYALURONIC ACID SYNTHASE 3 GENE; HYALURONIDASE 1 GENE; HYALURONIDASE 2 GENE; HYALURONIDASE 3 GENE; IN VITRO STUDY; INTERMETHOD COMPARISON; LIPID STORAGE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADIPOGENESIS; ADIPOSE TISSUE; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; GRAVES OPHTHALMOPATHY; HUMANS; HYALURONIC ACID; OBSERVER VARIATION; ORBIT; ORGAN SPECIFICITY; SUBCUTANEOUS FAT; TRANSCRIPTIONAL ACTIVATION;

EID: 84863011719     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1299     Document Type: Article

References (42)

1. Eckstein AK, Johnson KT, Thanos M, Esser J, Ludgate M 2009 Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res 41:456-464
2. Ludgate M, Baker G 2002 Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 127:193-198 (Pubitemid 34233922)
3. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
4. Bahn RS 2002 Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid 12:193-195 (Pubitemid 34259798)
5. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M 1997 Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 82:2003-2005 (Pubitemid 127495225)
6. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M 2003 Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol 30:369-380 (Pubitemid 36722625)
7. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 84:2557-2562
8. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M 2006 Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47:5197-5203 (Pubitemid 46723765)
9. Zhang L, Paddon C, Lewis MD, Grennan-Jones F, Ludgate M 2009 Gsα signalling suppresses PPARγ2 generation and inhibits 3T3L1 adipogenesis. J Endocrinol 202:207-215
10. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS 2011 A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol 46:155-163
11. Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, Steadman R, Ludgate M 2009 Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem 284:26447-26455
12. Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M, Evans C, Weetman A, Ludgate M 2002 Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab 87:1754-1761 (Pubitemid 34615265)
13. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AM, Boelen A 2011 Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid 21:169-176
14. Van Sande J, Lejeune C, Ludgate M, Munro DS, Vassart G, Dumont JE, Mockel J 1992 Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor. Mol Cell Endocrinol 88:R1-R5
15. Morshed SA, Latif R, Davies TF 2009 Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150:519-529
16. Morshed SA, Ando T, Latif R, Davies TF 2010 Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades. Endocrinology 151:5537-5549
17. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K 1999 Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085-25092
18. Kultti A, Kärnä R, Rilla K, Nurminen P, Koli E, Makkonen KM, Si J, Tammi MI, Tammi RH 2010 Methyl-β-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt. J Biol Chem 285:22901-22910
19. Billon N, Monteiro MC, Dani C 2008 Developmental origin of adipocytes: new insights into a pending question. Biol Cell 100:563-575
20. Allingham PG, Brownlee GR, Harper GS, Pho M, Nilsson SK, Brown TJ 2006 Gene expression, synthesis and degradation of hyaluronan during differentiation of 3T3-L1 adipocytes. Arch Biochem Biophys 452:83-91 (Pubitemid 44107334)
21. Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjerg A 2003 Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab 88:132-135 (Pubitemid 36115154)
22. Harrington LS, Findlay GM, Lamb RF 2005 Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 30:35-42 (Pubitemid 40093739)
23. Porcari AR, Townsend LB 2004 An improved total synthesis of triciribine: a tricyclic nucleoside with antineoplastic and antiviral properties. Nucleosides Nucleotides Nucleic Acids 23:31-39 (Pubitemid 38351960)
24. Hansson HA, Petruson B, Skottner A 1986 Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1:218-219 (Pubitemid 16135552)
25. Smith TJ 2003 The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 36:409-415 (Pubitemid 37160530)
26. Weightman DR, Perros P, Sherif IH, Kendall-Taylor P 1993 Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. Autoimmunity 16:251-257 (Pubitemid 24111622)
27. Gianoukakis AG, Douglas RS, King CS, Cruikshank WW, Smith TJ 2006 Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 147:1941-1949
28. Smith TJ, Hoa N 2004 Immunoglobulins from patients with Graves'disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab 89:5076-5080 (Pubitemid 39391451)
29. Imai Y, Odajima R, Inoue Y, Shishiba Y 1992 Effect of growth-factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture. Acta Endocrinol 126:541-552
30. Foster KG, Fingar DC 2010 Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285:14071-14077
31. Wan X, Harkavy B, Shen N, Grohar P, Helman LJ 2007 Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26:1932-1940 (Pubitemid 46474636)
32. Roy SK, Srivastava RK, Shankar S 2010 Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 5:10
33. Carlsson P, Mahlapuu M 2002 Forkhead transcription factors: key players in development and metabolism. Dev Biol 250:1-23
34. Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M, Ludgate M 2003 Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 144:4018-4030 (Pubitemid 37088757)
35. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
36. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM, Cheng JQ 2004 Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64:4394-4399 (Pubitemid 38856907)
37. Li J, Long X, Ke J, Meng QG, Lee WC, Doocey JM, Zhu F 2008 Regulation of HAS expression in human synovial lining cells of TMJ by IL-1β. Arch Oral Biol 53:60-65 (Pubitemid 350216087)
38. Makkonen KM, Pasonen-Seppänen S, Törrönen K, Tammi MI, Carlberg C 2009 Regulation of the hyaluronan synthase 2 gene by convergence in cyclic AMP response element-binding protein and retinoid acid receptor signaling. J Biol Chem 284:18270-18281
39. Saavalainen K, Tammi MI, Bowen T, Schmitz ML, Carlberg C 2007 Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor κB. J Biol Chem 282:11530-11539 (Pubitemid 47100742)
40. Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, Mauviel A, Böhm M 2010 Increased cAMP levels modulate transforming growth factor-β/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem 285:409-421
41. van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA 2009 Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 50:3091-3098
42. Guo N, Baglole CJ, O'Loughlin CW, Feldon SE, Phipps RP 2010 Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 via DP1 activation: implications for thyroid eye disease. J Biol Chem 285:15794-15804